Quetiapine Fumarate Tablet, Film Coated
Product Images NDC 0615-8474

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 0615-8474). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular Structure (Quetiapine Tabs 8470 8471 8472 8472 8474 1)

Chemical structure of quetiapine fumarate showing the molecular arrangement of the quetiapine moiety and fumarate ion in the compound.*

FDA Label Image

Principal Display Panel (200 MG)

This packaging label is for Quetiapine Tablets USP 200 mg by NCS HealthCare of KY, LLC dba Vangard Labs. It shows a lot number, expiration date fields, and indicates a quantity of 30 tablets. The label includes barcodes, storage instructions (20°-25°C), and states the product is for institutional use only. The manufacturer is Unichem, and packaging is done by Vanguard in Glasgow, KY.*

FDA Label Image

Principal Display Panel (300 MG)

This image shows a packaging label for Quetiapine Tablets USP 300 mg, film-coated oral tablets, labeled for institutional use only. The label includes multiple repeated barcodes, lot number 8474, and space for expiration date, with packaging by Vanguard Labs, Glasgow, KY. The label states each tablet contains quetiapine fumarate equivalent to 300 mg quetiapine, manufactured by Unichem.*

FDA Label Image

Figure 1 (Quetiapine Tabs 8470 8471 8472 8472 8474 2)

A line graph showing the proportion of patients with relapse (%) over time in weeks. Two curves compare relapse rates for QTP+LI/VAL (dashed line) and PLA+LI/VAL (solid line), illustrating different relapse profiles over a period up to 100 weeks.*

FDA Label Image

Figure 2 (Quetiapine Tabs 8470 8471 8472 8472 8474 3)

A line graph depicting the proportion of patients with relapse (%) over time (weeks). Two groups are compared: QTP+ LI/VAL (solid line) shows a higher relapse proportion increasing sharply early on and leveling off near 70%, while PLA+ LI/VAL (dashed line) remains lower, rising gradually to about 30% relapse over the 100-week period.*

FDA Label Image

Logo (Quetiapine Tabs 8470 8471 8472 8472 8474 4)

FDA Label Image

Principal Display Panel (25 mg)

Label for Quetiapine Tablets USP 25 mg, film-coated oral tablets, packaged by Vangard Labs, Glasgow, KY. The label includes dosage strength, lot number 8470, expiration date placeholder, quantity of 30 tablets, and storage instructions for controlled room temperature (20°-25°C). Multiple small barcode labels for institutional use are also visible.*

FDA Label Image

Principal Display Panel (25 MG)

Quetiapine Tablets USP 25 mg film-coated tablets, repackaged by Vangard Labs, Glasgow, KY, manufactured by Unichem. The label shows 30 tablets per quantity, with barcodes, lot number, and expiration date fields. The label states the drug is for prescription use only and provides storage temperature instructions.*

FDA Label Image

Principal Display Panel (50 MG)

Label for Quetiapine Tabs USP 50 mg film-coated tablets. The label includes multiple barcodes, lot number 8471, and space for expiration date. It instructs storage at controlled room temperature (20°-25°C). Marked for institutional use only and produced by NCS HealthCare of KY, LLC dba Vangard Labs in Glasgow, KY, with packaging by Unichem.*

FDA Label Image

Principal Display Panel (50 MG)

Label sheet for Quetiapine Fumarate Tablets USP 50 mg film-coated oral tablets packaged by Vangard Labs, Glasgow, KY. The sheet contains multiple individual labels each with the drug name, dosage strength, lot and expiration placeholders, barcode, and NDC 2930014801. The bottom section includes a combined label stating quantity of 30 tablets, storage instructions, manufacturer Unichem, and repackaging by Vangard Labs.*

FDA Label Image

Principal Display Panel (100 MG)

Label for Quetiapine Tablets USP 100 mg, film-coated oral tablets. The label shows the product name, strength, and lot number (8472-), with space for expiration date and quantity (30). Manufactured by Unichem and packaged by Vangard Labs, Glasgow, KY 42141. Includes multiple small barcode stickers for individual tablets and a dosing calendar for tracking administration. The label also notes storage conditions and states it is for institutional use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.